Banner

News

Video

GLP-1 RA antiobesity medications: Patients’ No. 1 question

Key Takeaways

  • Patients are curious about GLP-1 RA antiobesity medications, necessitating discussions with healthcare providers.
  • Dr. Robert Kushner, an expert in obesity and nutrition, stresses the importance of initiating these conversations.
SHOW MORE

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Patients have lots of questions regarding the new GLP-1 RA antiobesity medications. But there is a start to every conversation with their physician, nurse practitioner, or primary care provider, said Robert Kushner, MD, who has made a career as a researcher and author about overweight, obesity and nutrition. He’s also a doctor who has treated patients for years through Northwestern University’s Feinberg School of Medicine and Northwestern Medicine’s Center for Lifestyle Medicine.

Related Videos
Physician panelists discuss vaccine misinformation and policy in 2025
ACP policy update 2025 interview